Transvaginal color Doppler and CA125 as tools in the differential diagnosis of postmenopausal ovarian masses

Maturitas

Volumn 26, Issue 3, 1997, Pages 203-209

  Botsis, D ^a   Kassanos, D ^a   Kalogirou, D ^a   Karakitsos, P ^b   Liapis, A ^a   Antoniou, G ^a,c  

^a UNIVERSITY OF ATHENS   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

CA125; color Doppler imaging; ovarian cancer; transvaginal ultrasonography

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; TRANSVAGINAL ECHOGRAPHY; ULTRASOUND;

AGED; BLOOD FLOW VELOCITY; CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PULSATILE FLOW; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR RESISTANCE;

EID: 0030959002     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(96)01097-3     Document Type: Article

References (35)

1. Kurjak A, Kupesic S. Transvaginal color Doppler and pelvic tumor vascularity: lessons learned and future challenges. Ultrasound Obstet Gynecol 1995; 6: 145-159.
2. Bourne T, Campbell S, Steer C, Royston P, Whitehead M. Collins W. Transvaginal color flow imaging: A possible new screening test for ovarian cancer. Br Med J 1989; 289: 1367-1370.
3. Fleischer AC, Rodgers WH, Rao B, Kepple D, Jones H. Assessment of ovarian tumor vascularity with transvaginal color doppler sonography. J Ultrasound Med 1991; 10: 563-569.
4. Serov SF, Scully RE, Sobin LH. International histological classification of tumors No 9. Histological typing of ovarian tumors. Geneva: World Health Organization.
5. Timor-Tritsch IE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol 1993; 168: 909-913.
6. Fleischer AC, Jones III HW. Editorial: Color Doppler sonography of ovarian masses: the importance of a multiparameter approach. Gynecol Oncol 1993; 50: 1-2.
7. Hamper U, Sheth S. Abbas F, Rosenshein N, Aronson D, Kurman R. Transvaginal color Doppler sonography of adnexal masses: Differences in blood flow impedance in benign and malignant lesions. Am J Roentgenol 1993; 160: 1225-1228.
8. Hata T, Hata K, Senoh D. Doppler ultrasound assessment of tumor vascularity in gynecologic disorders. J Ultrasound Med 1989; 8: 309-314.
9. Granberg S, Norstrom A, Wikland M. Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 1990; 37: 224-229.
10. Kurjak A, Zalud I, Alfirevic Z. Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 1991; 10; 295-297.
11. Schneider V, Schneider A, Reed K, Hatch K. Comparison of Doppler with two-dimensional sonography and CA125 for prediction of malignancy of pelvic masses. Obstet Gynecol 1993; 81: 983-988.
12. Bourne TH. Transvaginal color Doppler in gynecology. Ultrasound Obstet Gynecol 1991; 1: 359-373.
13. Weiner Z, Thaler I, Beck D, Rottem S, Deutsch M, Brandes JM. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol 1992; 79: 159-162.
14. Karlan B, Laurence P. The current status of ultrasound and color Doppler imaging in screening for ovarian cancer. Gynecol Oncol 1994; 55: 28-33.
15. Tekay A, Jouppila P. Validity of pulsatility and resistance indices in classification of adnexal tumors with transvaginal color Doppler ultrasound. Ultrasound Obstet Gynecol 1992; 2: 338-344.
16. Carter J, Saltzman A, Hartenbach E, Fowler J, Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow doppler. Obstet Gynecol 1994; 83: 125-130.
17. Bourne TH. Should clinical decisions be made about ovarian masses using transvaginal color Doppler? Ultrasound Obstet Gynecol 1994; 4: 357-360.
18. Bourne TH, Campbell S, Steer C, Whithelhead MI, Collins WP. Screening for early familial ovarian cancer with transvaginal ultrasonography and color flow imaging. Br Med J 1993; 306: 1025-1029.
19. Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren W. Transvaginal sonographic characterization of ovarian disease. Obstet Gynecol 1991; 78: 70-76.
20. Hata K, Hata T, Manabe A, Sugimura K, Manabu K. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA125 in detecting ovarian cancer. Obstet Gynecol 1992; 80: 922-926.
21. Valentin L, Sladkevicius P, Marsal K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 1994; 83: 425-433.
22. Jacobs I, Bast RC. The CA125 tumour-associated antigen: A review of the literature. Hum Reprod 1989; 4: 1-12.
23. Van Nagell Jr JR. Ovarian cancer [editorial]. Gynecol Oncol 1991; 43: 89-91.
24. Sparks JM, Varner RE. Ovarian cancer screening. Obstet Gynecol 1991; 77: 787-792.
25. Antonic J, Rakar S. Validity of colour and pulsed Doppler US and tumour marker CA125 in differentiation between benign and malignant ovarian masses. Eur J Gynaecol Oncol 1996; 1: 29-35.
26. Oram D, Jeyarajah A. The role of ultrasound and tumour markers in the early detection of ovarian cancer. Br J Obstet Gynaecol 1994; 101: 939-945.
27. Fleischer AC, Rogers WH, Rao BK, Kepple DM, Jones HW. Transvaginal color Doppler sonography of ovarian masses with pathological correlation. Ultrasound Obstet Gynecol 1991; 1: 275-278.
28. Kawai M, Kano T, Kikkawa F, Maeda O, Oguchi H, Tomoda Y. Transvaginal Doppler ultrasound with color flow imaging in the diagnosis of ovarian cancer. Obstet Gynecol 1992; 79: 163-167.
29. Cohen C, Jennings S. Screening for ovarian cancer: the role of noninvasive imaging techniques. Am J Obstet Gynecol 1994; 170: 1088-1094.
30. Droegemueller W. Screening for ovarian carcinoma: Hopeful and wishful thinking. Am J Obstet Gynecol 1994; 170: 1095-1098.
31. van Nagell JR. Methods to improve the diagnostic accuracy of ultrasound in the detection of ovarian cancer. Gynecol Oncol 1994; 54: 115-116.
32. Edlich RG, Rogers W, DeShazo CV, Aust JB. Effect of vasoactive drugs on tissue blood flow in the hamster melanoma. Cancer Res 1996; 26: 1420-1424.
33. Kurjak A, Zalud I, Alfirevic Z. Transvaginal Farbdoppler fur die Beurteilung von gynakologischen Pathologien im Kleinen Becken. Ultraschall Med 1990; 11: 164-168.
34. Kurjak A, Schulman H, Sosic A, Zalud I, Shalan H. Transvaginal ultrasound, color flow and doppler waveform of the postmenopausal adnexal mass. Obstet Gynecol 1992; 80: 917-921.
35. Sladkevicius P, Valentin L, Marsal K. Transvaginal gray-scale and Doppler ultrasound examinations of the uterus and ovaries in healthy postmenopausal women. Ultrasound Obstet Gynecol 1995; 6: 81-90.